A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration

Stopped early · Not applicable

Conditions studied: End Stage Renal Disease

In brief

The purpose of the TiME Trial is to determine whether dialysis facility implementation of a minimum hemodialysis session duration of 4.25 hours (versus usual care) for patients with end-stage renal disease initiating treatment with thrice weekly maintenance hemodialysis has benefits on mortality, hospitalizations and health-related quality of life. The trial also aims to demonstrate the capacity to conduct a large, pragmatic clinical trial in partnership with two large dialysis provider organizations.

Key facts

Study ID

NCT02019225

Run by

University of Pennsylvania

People needed

7053

Starts

2013-12-18

Expected to finish

2017-04-30

Last updated by the study team

2019-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Unwillingness to participate.
• Inability to provide consent for dialysis care.

Where it is running

• Fresenius Medical Care North America — Waltham, Massachusetts, United States
• DaVita Clinical Research — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.